-
Innovation Ranking
NewInnovation Ranking – Screen Holdings Co Ltd
Screen Holdings Co Ltd (Screen) is a manufacturer of semiconductor, electronic equipment and components. The company manufactures and markets single wafer cleaning equipment, batch-type cleaning equipment, spin scrubber, coater and developer, annealing equipment, wafer pattern inspection and measurement equipment and direct imaging equipment. It also produces computer to plate (CTP) equipment, digital printing equipment, direct imaging equipment, inspection equipment, digital precision measurement and in-vehicle technology equipment. Screen also offers life science products such as compact, inkjet, and ultraviolet printing system...
-
Track & Monitor
NewInnovation in pharma: phenotypic drug screening
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s phenotypic drug screening segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Sector Analysis
Prenatal Screening Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Prenatal Screening Market Report Overview The prenatal screening market size was $672.8 million in 2023. The market is expected to grow at a CAGR of more than 1% during 2023-2033. Pre-natal screening describes tests that detect potential problems affecting the viability and development of the fetus. The detection is carried out using both less invasive and more invasive sampling techniques. Prenatal Screening Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the Prenatal Screening Market Forecast...
-
Product Insights
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Colorectal Cancer Screening Tests Pipeline Market Report Overview The colorectal cancer screening Tests pipeline market research report provides comprehensive information about the colorectal cancer screening tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments · Other Colorectal Cancer Screening Tests · Fecal DNA Test Kits · Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits Key Territories · The US · Europe...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FPT-155 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FPT-155 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FPT-155 in Triple-Negative Breast Cancer (TNBC) Drug Details: FPT-155 is...
-
Thematic Analysis
NewWealth Management Sector Scorecard – Thematic Intelligence
Wealth Management Sector Scorecard Thematic Intelligence Report Overview The wealth management sector must continuously invest in key themes to capture more market share. Digital investment platforms with the infusion of emerging technologies, such as artificial intelligence (AI) and machine learning, can offer customers efficient personalized services. This will not only help players retain customers but also gain a competitive advantage. Environmental, social, and governance (ESG) services remain a key theme in the wealth space, accelerated due to the pandemic. Wealth...
-
Product Insights
NewLikelihood of Approval Analysis for Human Papillomavirus Infections
Overview How likely is it that the drugs in Human Papillomavirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Human Papillomavirus Infections Overview Human Papillomavirus (HPV) infections are common sexually...
-
Product Insights
NewLikelihood of Approval Analysis for Genital Warts (Condylomata Acuminata)
Overview How likely is it that the drugs in Genital Warts (Condylomata Acuminata) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Genital Warts (Condylomata Acuminata) Overview Genital warts (condyloma acuminatum) are...
-
Product Insights
NewLikelihood of Approval Analysis for Hepatitis B
Overview How likely is it that the drugs in Hepatitis B will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepatitis B Overview Hepatitis B, a viral infection affecting the liver, poses...